Date: 6.9.2013
Technology offer: Specific thrombin inhibitors for the development of anticoagulant
Reference: TOES20130801002
Summary: A Spanish public research organization and a University from Venezuela have developed a new protein with inhibitory activity against thrombin. Compared to other thrombin inhibitors, the protein is most selective and could be used as anticoagulant reducing side effects related to these compounds. Pharmaceutical or biotech companies are sought for further development under a license agreement.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
ScienceWeek - Biotechnology Science since 1997
Biotechnology organizations - Biotech research institute, company, university, ..
New method uses nanoparticles to reprogram exhausted immune cells
New technology protects crops by testing the air for the DNA of plant diseases